vs
Side-by-side financial comparison of Aquestive Therapeutics, Inc. (AQST) and FVCBankcorp, Inc. (FVCB). Click either name above to swap in a different company.
FVCBankcorp, Inc. is the larger business by last-quarter revenue ($16.9M vs $13.0M, roughly 1.3× Aquestive Therapeutics, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 9.7%). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $-8.6M). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs 3.9%).
Aquestive Therapeutics is a specialty pharmaceutical company focused on developing and commercializing innovative treatments for central nervous system disorders. It leverages proprietary drug delivery technologies to create accessible, patient-friendly therapeutic options, serving healthcare providers and patients across North America and European markets, with core offerings addressing unmet needs in neurology and psychiatry.
FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.
AQST vs FVCB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.0M | $16.9M |
| Net Profit | $-31.9M | — |
| Gross Margin | 55.2% | — |
| Operating Margin | -221.6% | 43.7% |
| Net Margin | -244.8% | — |
| Revenue YoY | 9.7% | 4377.5% |
| Net Profit YoY | -86.8% | — |
| EPS (diluted) | $-0.26 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.0M | $16.9M | ||
| Q3 25 | $12.8M | $416.0K | ||
| Q2 25 | $10.0M | $15.8M | ||
| Q1 25 | $8.7M | $382.0K | ||
| Q4 24 | $11.9M | $378.0K | ||
| Q3 24 | $13.5M | $412.0K | ||
| Q2 24 | $20.1M | $415.0K | ||
| Q1 24 | $12.1M | $359.0K |
| Q4 25 | $-31.9M | — | ||
| Q3 25 | $-15.4M | $5.6M | ||
| Q2 25 | $-13.5M | $5.7M | ||
| Q1 25 | $-22.9M | $5.2M | ||
| Q4 24 | $-17.1M | — | ||
| Q3 24 | $-11.5M | $4.7M | ||
| Q2 24 | $-2.7M | $4.2M | ||
| Q1 24 | $-12.8M | $1.3M |
| Q4 25 | 55.2% | — | ||
| Q3 25 | 64.8% | — | ||
| Q2 25 | 54.4% | — | ||
| Q1 25 | 58.1% | — | ||
| Q4 24 | 61.9% | — | ||
| Q3 24 | 67.2% | — | ||
| Q2 24 | 77.5% | — | ||
| Q1 24 | 63.6% | — |
| Q4 25 | -221.6% | 43.7% | ||
| Q3 25 | -89.6% | — | ||
| Q2 25 | -113.6% | 45.9% | ||
| Q1 25 | -222.1% | — | ||
| Q4 24 | -114.4% | — | ||
| Q3 24 | -61.2% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | -74.3% | — |
| Q4 25 | -244.8% | — | ||
| Q3 25 | -120.6% | 1341.1% | ||
| Q2 25 | -135.4% | 36.0% | ||
| Q1 25 | -263.0% | 1352.1% | ||
| Q4 24 | -143.7% | — | ||
| Q3 24 | -85.0% | 1133.3% | ||
| Q2 24 | -13.7% | 1001.2% | ||
| Q1 24 | -106.4% | 373.3% |
| Q4 25 | $-0.26 | $0.31 | ||
| Q3 25 | $-0.14 | $0.31 | ||
| Q2 25 | $-0.14 | $0.31 | ||
| Q1 25 | $-0.24 | $0.28 | ||
| Q4 24 | $-0.18 | $0.27 | ||
| Q3 24 | $-0.13 | $0.25 | ||
| Q2 24 | $-0.03 | $0.23 | ||
| Q1 24 | $-0.17 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $27.5M | — |
| Stockholders' EquityBook value | $-33.7M | $253.6M |
| Total Assets | $160.4M | $2.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $129.1M | — | ||
| Q2 25 | $60.5M | — | ||
| Q1 25 | $68.7M | — | ||
| Q4 24 | $71.5M | — | ||
| Q3 24 | $77.9M | — | ||
| Q2 24 | $89.9M | — | ||
| Q1 24 | $95.2M | — |
| Q4 25 | $27.5M | — | ||
| Q3 25 | $45.0M | — | ||
| Q2 25 | $45.0M | — | ||
| Q1 25 | $45.0M | — | ||
| Q4 24 | $32.5M | — | ||
| Q3 24 | $45.0M | — | ||
| Q2 24 | $45.0M | — | ||
| Q1 24 | $45.0M | — |
| Q4 25 | $-33.7M | $253.6M | ||
| Q3 25 | $-4.1M | $249.8M | ||
| Q2 25 | $-72.6M | $243.2M | ||
| Q1 25 | $-60.9M | $242.3M | ||
| Q4 24 | $-60.2M | $235.4M | ||
| Q3 24 | $-45.4M | $230.8M | ||
| Q2 24 | $-35.5M | $226.5M | ||
| Q1 24 | $-36.3M | $220.7M |
| Q4 25 | $160.4M | $2.3B | ||
| Q3 25 | $163.6M | $2.3B | ||
| Q2 25 | $93.7M | $2.2B | ||
| Q1 25 | $102.2M | $2.2B | ||
| Q4 24 | $101.4M | $2.2B | ||
| Q3 24 | $110.0M | $2.3B | ||
| Q2 24 | $117.6M | $2.3B | ||
| Q1 24 | $129.5M | $2.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.5M | $23.9M |
| Free Cash FlowOCF − Capex | $-8.6M | $23.8M |
| FCF MarginFCF / Revenue | -65.7% | 140.7% |
| Capex IntensityCapex / Revenue | 0.7% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-53.0M | $40.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.5M | $23.9M | ||
| Q3 25 | $-12.6M | $7.6M | ||
| Q2 25 | $-7.9M | $3.3M | ||
| Q1 25 | $-23.4M | $5.4M | ||
| Q4 24 | $-6.5M | $18.2M | ||
| Q3 24 | $-11.9M | $4.7M | ||
| Q2 24 | $-7.0M | $1.6M | ||
| Q1 24 | $-10.4M | $7.2M |
| Q4 25 | $-8.6M | $23.8M | ||
| Q3 25 | $-12.9M | $7.6M | ||
| Q2 25 | $-8.0M | $3.3M | ||
| Q1 25 | $-23.5M | $5.4M | ||
| Q4 24 | $-6.5M | $18.1M | ||
| Q3 24 | $-12.0M | $4.6M | ||
| Q2 24 | $-7.0M | $1.5M | ||
| Q1 24 | $-10.4M | $7.1M |
| Q4 25 | -65.7% | 140.7% | ||
| Q3 25 | -100.6% | 1818.0% | ||
| Q2 25 | -80.2% | 20.8% | ||
| Q1 25 | -269.9% | 1413.6% | ||
| Q4 24 | -54.8% | 4786.0% | ||
| Q3 24 | -88.3% | 1121.8% | ||
| Q2 24 | -35.0% | 361.2% | ||
| Q1 24 | -86.4% | 1988.3% |
| Q4 25 | 0.7% | 0.3% | ||
| Q3 25 | 1.8% | 0.2% | ||
| Q2 25 | 1.1% | 0.1% | ||
| Q1 25 | 1.5% | 4.2% | ||
| Q4 24 | 0.1% | 37.3% | ||
| Q3 24 | 0.6% | 14.1% | ||
| Q2 24 | 0.2% | 12.8% | ||
| Q1 24 | 0.2% | 3.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.37× | ||
| Q1 24 | — | 5.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
